Literature DB >> 9201043

Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome.

M A Hayes1, A C Timmins, E H Yau, M Palazzo, D Watson, C J Hinds.   

Abstract

OBJECTIVE: To investigate the relationship between oxygen transport patterns and outcome in patients with sepsis syndrome or septic shock managed according to two different treatment regimens.
DESIGN: Retrospective study of a subgroup of patients with sepsis syndrome or septic shock taken from a randomized, prospective, controlled trial.
SETTING: General intensive care units in a teaching and a district general hospital. PATIENTS: Seventy-eight patients classified according to predetermined criteria as having sepsis syndrome or septic shock were drawn retrospectively from a larger study group of 109 consecutive patients considered to be at risk for developing multiple organ failure.
INTERVENTIONS: All patients received volume expansion to an optimal pulmonary artery occlusion pressure. If the therapeutic goals (cardiac index of > 4.5 L/min/m2, oxygen delivery [DO2] of > 600 mL/min/m2, and oxygen consumption [VO2] of > 170 mL/min/m2) were not achieved with fluids alone, patients were randomized to either a control group or a treatment group. In the treatment group, dobutamine (5 to 200 micrograms/kg/min) was administered to increase cardiac index and DO2 until all three goals were simultaneously achieved. In the control group, dobutamine was administered only if the cardiac index was < 2.8 L/min/m2. In both groups, norepinephrine was infused to maintain mean arterial pressure at 80 mm Hg.
MEASUREMENTS AND MAIN RESULTS: Hemodynamic, oxygen transport, and lactate measurements were made at the time of admission to the study, at the time of optimal volume administration, at 1, 2, 4, 8, 12, 16, 20, and 24 hrs, then every 6 hrs for the next 24 hrs, and at least every 8 hrs thereafter. The time at which all therapeutic goals were first achieved simultaneously or the time of maximal DO2 was identified and termed "tmax." Survivors from both the control and treatment groups significantly (p < .001) increased cardiac index and DO2 in response to maximal resuscitation, and despite an associated decrease in oxygen extraction (p < .01), there was a significant (p < .01) increase in VO2. In nonsurvivors from both groups, despite significant increases in cardiac index (p < .05) and DO2 (p < .01) at tmax, oxygen extraction decreased (p < .01) and VO2 remained unchanged. DO2 and VO2 were significantly lower (p < .05) at tmax in nonsurvivors than in survivors from both groups. Persistently high lactate concentrations were characteristic of nonsurvivors.
CONCLUSIONS: Survivors of sepsis syndrome or septic shock are characterized by an ability to increase both DO2 and VO2. In contrast, nonsurvivors typically have reduced cardiac reserve, they fail to increase VO2 following resuscitation, and when delivery is enhanced with aggressive inotropic support, oxygen extraction falls. These patterns of response were similar in both treatment and control groups, although the magnitude of the changes was exaggerated in the treatment group. These observations may help to explain the findings by some investigators that treatment aimed at achieving survivor values of cardiac index, DO2, and VO2 fails to improve outcome when instituted following admission to intensive care.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201043     DOI: 10.1097/00003246-199706000-00007

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Pharmacological optimization of tissue perfusion.

Authors:  N Mongardon; A Dyson; M Singer
Journal:  Br J Anaesth       Date:  2009-05-21       Impact factor: 9.166

2.  Temporal changes in tissue cardiorespiratory function during faecal peritonitis.

Authors:  Alex Dyson; Alain Rudiger; Mervyn Singer
Journal:  Intensive Care Med       Date:  2011-04-30       Impact factor: 17.440

3.  Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis.

Authors:  Hao Wang; Zhen-Huan Zhang; Xiao-Wen Yan; Wei-Qin Li; Da-Xi Ji; Zhu-Fu Quan; De-Hua Gong; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 4.  The evolving concepts of haemodynamic support: from pulmonary artery catheter to echocardiography and theragnostics.

Authors:  Antonio Figueiredo; Nuno Germano; Pedro Guedes; Paulo Marcelino
Journal:  Curr Cardiol Rev       Date:  2011-08

5.  Should we use early less invasive hemodynamic monitoring in unstable ICU patients?

Authors:  Maurizio Cecconi; David Bennett
Journal:  Crit Care       Date:  2011-07-28       Impact factor: 9.097

Review 6.  Bench-to-bedside review: sepsis - from the redox point of view.

Authors:  Michael Éverton Andrades; Arian Morina; Snežana Spasić; Ivan Spasojević
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

7.  Time course of endothelial damage in septic shock: prediction of outcome.

Authors:  Ortrud Vargas Hein; Klaudia Misterek; Jan-Peer Tessmann; Vera van Dossow; Michael Krimphove; Claudia Spies
Journal:  Crit Care       Date:  2005-05-13       Impact factor: 9.097

Review 8.  Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure.

Authors:  Alessandro Protti; Mervyn Singer
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Red Blood Cell Transfusion at a Hemoglobin Threshold of 7 g/dl in Critically Ill Patients: A Regression Discontinuity Study.

Authors:  Nicholas A Bosch; Anica C Law; Jacob Bor; Laura C Myers; Nareg H Roubinian; Vincent X Liu; Allan J Walkey
Journal:  Ann Am Thorac Soc       Date:  2022-07

Review 10.  Energetic dysfunction in sepsis: a narrative review.

Authors:  Sebastien Preau; Dominique Vodovar; Boris Jung; Steve Lancel; Lara Zafrani; Aurelien Flatres; Mehdi Oualha; Guillaume Voiriot; Youenn Jouan; Jeremie Joffre; Fabrice Uhel; Nicolas De Prost; Stein Silva; Eric Azabou; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2021-07-03       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.